The Misfit Toys of Hong Kong Equities: Who is Actually Working and Who is Faking ItGlobal Report·Aug 13 at 04:43 AM02005-0.62%015460.00%
SSY Group says China regulator approves ziprasidone hydrochloride as bulk drugPUBT·Aug 7 at 04:04 AM02005-0.62%
SSY Group wins China NMPA approval for cimetidine injection registrationPUBT·Jul 30 at 03:34 AM02005-0.62%
SSY Group wins China NMPA approval for sodium citrate hemofiltration replacement fluidPUBT·Jul 23 at 03:32 AM02005-0.62%
SSY Group says China grants NMPA registration approval for Gadobutrol bulk drugPUBT·Jul 20 at 06:54 PM02005-0.62%
SSY Group Wins China Approval for Next-Generation Lipid-Lowering CapsuleTip Ranks·Jul 15 at 11:37 PM02005-0.62%
SSY Group wins China NMPA approval for choline fenofibrate sustained-release capsulesPUBT·Jul 15 at 11:09 PM02005-0.62%
SSY Group says China regulator approves Baloxavir Marboxil bulk drug registrationPUBT·Jul 12 at 11:01 PM02005-0.62%
SSY Group says 95 product types added to China national essential medicines listPUBT·Jul 9 at 11:02 PM02005-0.62%